Skip to main content
Journal of Public Health (Oxford, England) logoLink to Journal of Public Health (Oxford, England)
. 2021 May 5;44(1):e106–e116. doi: 10.1093/pubmed/fdab122

Correlates of COVID-19 vaccine hesitancy in Austria: trust and the government

Eva Schernhammer 1,2,3, Jakob Weitzer 4, Manfred D Laubichler 5,6,7, Brenda M Birmann 8, Martin Bertau 9, Lukas Zenk 10, Guido Caniglia 11, Carlo C Jäger 12, Gerald Steiner 13,14,
PMCID: PMC8135852  PMID: 33948665

Abstract

Background

With the coronavirus disease 2019 (COVID-19) pandemic surging and new mutations evolving, trust in vaccines is essential.

Methods

We explored correlates of vaccine hesitancy, considering political believes and psychosocial concepts, conducting a non-probability quota-sampled online survey with 1007 Austrians.

Results

We identified several important correlates of vaccine hesitancy, ranging from demographics to complex factors such as voting behavior or trust in the government. Among those with hesitancy towards a COVID-19 vaccine, having voted for opposition parties (opp) or not voted (novote) were (95% Confidence Intervall (CI)opp, 1.44–2.95) to 2.25-times (95%CInovote, 1.53–3.30) that of having voted for governing parties. Only 46.2% trusted the Austrian government to provide safe vaccines, and 80.7% requested independent scientific evaluations regarding vaccine safety to increase willingness to vaccine.

Conclusions

Contrary to expected, psychosocial dimensions were only weakly correlated with vaccine hesitancy. However, the strong correlation between distrust in the vaccine and distrust in authorities suggests a common cause of disengagement from public discourse.

Keywords: behaviour, communicable diseases, vaccine hesitancy, COVID-19

Introduction

Austria was among the first countries in Europe to report coronavirus disease 2019 (COVID-19) cases at the beginning of the pandemic.1 In response to the first and second wave of COVID-19, complete lockdown measures were implemented in Austria for 6 weeks between March 16 and 25 April 2020; and then again—with some interruption during the Christmas holidays in December—from 3 November 2020 through 8 February 2021.2

As the COVID-19 pandemic continues to surge worldwide, recent approvals of COVID-19 vaccines raise hope for a light at the end of the long and dark tunnel. But COVID-19 vaccination programs can affect meaningful resolution only with sufficient participation rates to achieve herd immunity. While a global survey from June 2020 revealed promising levels of potential COVID-19 vaccine acceptance (55–89%),3 in September, only 51% of US adults indicated willingness to be vaccinated. Similarly, also in other countries, COVID-19 risk perception and vaccine intentions have fluctuated throughout the pandemic.4–6 Acceptance levels for restrictions and trust in authorities has diminished, fueled in part by political polarization7; and difficulties with the vaccine roll-out and hesitancy towards a COVID-19 vaccine has increased.

In order to better deal with the underlying complexity of pandemic threats, our aim was to extend on the study by Volpp et al.,8 providing additional data in support of their core request of rebuilding trust in the rigor of vaccine trials and the integrity of the approval process. Specifically, we conducted a non-probability online survey, which was conducted during the period of the second lockdown and quota sampled to match the population in Austria for age, gender, and region. We explored attitudes and reasons for behavior towards governmentally mandated lockdown measures and correlates of vaccine hesitancy, including political views, voting behavior and also considering psychosocial concepts such as optimism, altruism, resilience, and need for cognitive closure, as well as altruistic reasons for behavior.

Results

The median age of the whole sample was 42 years (interquartile range = 32–52). Of all 1007 survey respondents (498 men, 509 women), 414 (41.1%) reported intermediate or severe vaccine hesitancy [women: 236 (46.4%); men 178 (35.7%)], 230 men and women (22.8%) were undecided and 363 (36.1%) reported no or little hesitancy towards receiving a COVID-19 vaccine once available. Adherence to governmentally implemented COVID-19 measures partially or total was high (91.1%). Overall, vaccine hesitancy (intermediate or high) was more frequent among those aged 35–54 (51.1% versus 7.7% for those ages 60+), living in rural areas [towns or cities with <50.000 inhabitants; 54.8% versus 41.1% for those living in urban areas)], with a high school education or less (46.1% versus 33.6% with education levels higher than high school). Among participants who reported having voted for the political parties currently in power in Austria, 55.4% had little or no hesitancy towards a COVID-19 vaccine, compared to 26.7% (having voted for the opposition parties) and 17.9% among those who did not vote during the last national election. Further, vaccine acceptance was higher among those with high optimism (30.9%) compared to those with low optimism (19.4%), whereas vaccine hesitancy was high among those with high self-reported resilience (32.1%) versus those with low resilience (22.2%). Among those with least vaccine hesitancy, the least frequently used main sources of information about the pandemic were social media (14.6%) and friend/kin (9.6%), whereas in particular among those who were undecided regarding vaccine, social media were more frequently used as main source of information (21.7%). The most frequent reasons overall that were listed by participants why they did or did not follow the imposed Corona guidelines were ‘to protect own health’ (60.3%) and ‘to protect my family’s health’ (55.3%). Among those with little hesitancy towards a COVID-19 vaccine, 59.8% stated that they followed the Corona measures because they approved them; whereas among those with high hesitancy, 56.6% stated that they did not follow imposed measures because they did not approve them (Table 1). The question whether participants had trust in the Austrian government to provide a safe COVID-19 vaccine was answered with ‘yes, definitely’ by 10% of the overall sample, and 26.8% answered ‘definitely not’ (27% said ‘rather not’, and 36.2% ‘rather yes’). By contrast, 80.7% reported that an independent scientific evaluation of vaccine safety would (‘yes, definitely’, or ‘rather yes’) increase their willingness to get vaccinated.

Table 1.

Sample characteristics across vaccine hesitancy in a sample (N = 1007) of the Austrian adult population

Characteristics Vaccine hesitancy
No or little hesitancy (n = 363) Undecided (n = 230) Intermediate or high hesitancy (n = 414)
n (%) n (%) n (%)
Gender
 Men 203 (55.9) 117 (50.9) 178 (43.0)
Age
 <35 years 106 (29.2) 91 (39.6) 124 (30.0)
 35–54 years 147 (40.5) 105 (45.6) 224 (54.1)
 55–59 years 53 (14.6) 20 (8.7) 34 (8.2)
 ≥60 years 57 (15.7) 14 (6.1) 32 (7.7)
Region of residence
 Burgenland 13 (3.6) 8 (3.5) 17 (4.1)
 Carinthia 22 (6.1) 10 (4.4) 28 (6.7)
 Lower Austria 66 (18.2) 49 (21.3) 96 (23.2)
 Salzburg 17 (4.7) 15 (6.5) 30 (7.3)
 Styria 53 (14.6) 27 (11.7) 57 (13.8)
 Tyrol 21 (5.8) 18 (7.8) 28 (6.8)
 Upper Austria 51 (14.1) 26 (11.3) 54 (13.0)
 Vienna 113 (31.1) 70 (30.4) 79 (19.1)
 Vorarlberg 7 (1.9) 7 (3.0) 25 (6.0)
Area of residence
 Urban 197 (54.3) 105 (45.6) 170 (41.1)
 Rural 166 (45.7) 125 (54.4) 244 (58.9)
Education
 High school or less 123 (33.9) 86 (37.4) 191 (46.1)
 Matura (university entry exam) 148 (40.8) 96 (41.7) 139 (33.6)
 University degree 92 (25.3) 48 (20.9) 84 (20.3)
 Child, <16 years 85 (23.4) 75 (32.6) 118 (28.5)
Political party preference
 Governing 201 (55.4) 124 (53.9) 154 (37.2)
 Opposition 97 (26.7) 54 (23.5) 135 (32.6)
 Did not vote (last elections) 65 (17.9) 52 (22.6) 125 (30.2)
Optimism [quartiles]
 Low 71 (19.4) 27 (11.7) 90 (21.7)
 Low-intermediate 83 (22.9) 83 (36.1) 117 (28.3)
 Intermediate-high 97 (26.8) 61 (26.5) 94 (22.7)
 High 112 (30.9) 59 (25.7) 113 (27.3)
Resilience [quartiles]
 Low 80 (22.0) 73 (31.8) 92 (22.2)
 Low-intermediate 99 (27.3) 58 (25.2) 101 (24.4)
 Intermediate-high 86 (23.7) 50 (21.7) 88 (21.3)
 High 98 (27.0) 49 (21.3) 133 (32.1)
Need for cognitive closure [quartiles]
 Low 94 (25.9) 58 (25.2) 91 (21.9)
 Low-intermediate 82 (22.6) 72 (31.3) 103 (24.9)
 Intermediate-high 83 (22.9) 44 (19.1) 98 (23.7)
 High 104 (28.7) 56 (24.4) 122 (29.5)
Main source to inform oneself about measures/recommendations
 TV 216 (59.5) 100 (43.5) 226 (54.6)
 Newspaper (paper format) 76 (20.9) 35 (15.2) 70 (16.9)
 Newspaper (online format) 102 (28.1) 54 (23.5) 99 (23.9)
 Radio 69 (19.0) 37 (16.1) 69 (16.7)
 Official web pages of the Austrian ministries 86 (23.7) 61 (26.5) 62 (15.0)
 Social media 53 (14.6) 50 (21.7) 99 (23.9)
 Friends/kin 35 (9.6) 27 (11.7) 44 (10.6)
Frequency of informing oneself
 More than once a day 131 (36.1) 66 (28.7) 91 (22.0)
 Once a day 147 (40.5) 84 (36.5) 164 (39.6)
 Several times a week 68 (18.7) 55 (23.9) 87 (21.0)
 Weekly or less often 17 (4.7) 25 (10.9) 72 (17.4)
Perceived risk of infection between June–October 2020
 Negligible 38 (10.5) 20 (8.7) 100 (24.2)
 Low 156 (42.9) 116 (50.4) 186 (44.9)
 Intermediate 124 (34.2) 73 (31.7) 94 (22.7)
 High 45 (12.4) 21 (9.1) 34 (8.2)
Subjective health status
 Very good 97 (26.7) 55 (23.9) 128 (30.9)
 Good 185 (51.0) 116 (50.4) 175 (42.3)
 Fair, bad or very bad 81 (22.3) 59 (25.7) 111 (26.8)
Overall adherence to measures
 Yes, to protect my health 279 (79.5) 146 (68.5) 182 (50.4)
 Yes, do want to quarantine 112 (31.9) 62 (29.1) 95 (26.3)
 Yes, do approve measures 210 (59.8) 105 (49.3) 114 (31.6)
 Yes, to protect my family’s health 247 (70.4) 133 (62.4) 177 (49.0)
 Yes, to protect the population’s health 192 (54.7) 90 (42.3) 101 (28.0)
 Yes, the government said so 92 (26.2) 46 (21.6) 112 (31.0)
 Yes, do not want to cause death 136 (38.8) 68 (31.9) 72 (19.9)
 No, COVID-19 is no danger 4 (33.3) 5 (29.4) 20 (37.7)
 No, did not approve measures 6 (50.0) 8 (47.1) 30 (56.6)
 No, did not understand measures 3 (25.0) 3 (17.7) 9 (17.0)
 No, burden for economy 1 (8.3) 5 (29.4) 11 (20.8)
 No, social burden 3 (25.0) 3 (17.8) 21 (39.6)
Change in quality of life (compared to before COVID)
 Decrease 109 (30.0) 74 (32.2) 129 (31.2)
 No change 212 (58.4) 125 (54.3) 239 (57.7)
 Increase 42 (11.6) 31 (13.5) 46 (11.1)

Next, we examined associations between correlates of vaccine hesitancy taking into account potential confounders. Because results from age- and multivariable models were largely similar, we focused on the multivariable results (Table 2). Men were significantly less likely than women to report (intermediate or high) vaccine hesitancy (odds ratio (OR) = 0.56; 95%CI, 0.41–0.76). Compared to those aged 35 or younger, vaccine hesitancy appeared to decline with increasing age (OR35-54yrs = 1.20, 95%CI, 0.83–1.73; OR55-59yrs = 0.48, 95%CI, 0.28–0.84; and OR60 + yrs = 0.37, 95%CI, 0.21–0.66). Further, compared to those who live in urban areas, those in smaller rural areas had a significantly higher odds of intermediate to high vaccine hesitancy (OR = 1.86, 95%CI, 1.36–2.54). The highest odds of expressing vaccine hesitancy was reported by those who voted for opposition parties (OR = 2.06; 95%CI, 1.44–2.95) and those who did not vote during the last national election (OR = 2.25; 95%CI, 1.53–3.30). Individuals with intermediate to high optimism were significantly less likely to express vaccine hesitancy (OR = 0.71; 95%CI, 0.51–0.99). Resilience, need for cognitive closure, preferred main source of information regarding Corona, and subjective health status did not correlate significantly with vaccine hesitancy.

Table 2.

Correlates of vaccine hesitancy in a sample (N = 1007) of the Austrian adult population

Vaccine hesitancy
No or little hesitancy (N = 363) Undecided (N = 230) Intermediate or high hesitancy (N = 414)
N (%) N (%) OR (95% CI)* N (%) OR (95% CI)*
Gender
 Men 230 (55.9) 117 (50.9) 0.80 (0.57–1.13) 178 (43.0) 0.56 (0.41–0.76)
Age
 <35 year 106 (29.2) 91 (39.6) 1 124 (30.0) 1
 35–54 year 147 (40.5) 105 (45.6) 0.82 (0.54–1.23) 224 (54.1) 1.20 (0.83–1.73)
 55–59 year 53 (14.6) 20 (8.7) 0.40 (0.22–0.76) 34 (8.2) 0.48 (0.28–0.84)
 ≥60 year 57 (15.7) 14 (6.1) 0.27 (0.14–0.54) 32 (7.7) 0.37 (0.21–0.66)
Area of residence
 Urban 197 (54.3) 105 (45.6) 1 170 (41.1) 1
 Rural ≥ 50 K 20 (5.5) 14 (6.1) 1.36 (0.65–2.85) 17 (4.1) 0.98 (0.48–1.99)
 Rural < 50 K 146 (40.2) 111 (48.3) 1.45 (1.02–2.07) 227 (54.8) 1.86 (1.36–2.54)
Education
 Middle school or less 123 (33.9) 86 (37.4) 1 191 (46.1) 1
 High school 148 (40.8) 96 (41.7) 0.82 (0.55–1.22) 139 (33.6) 0.64 (0.45–0.91)
 University degree 92 (25.3) 48 (20.9) 0.66 (0.41–1.05) 84 (20.3) 0.58 (0.39–0.88)
Political party preference
 Governing 201 (55.4) 124 (53.9) 1 154 (37.2) 1
 Opposition 97 (26.7) 54 (23.5) 1.00 (0.66–1.52) 135 (32.6) 2.06 (1.44–2.95)
 Did not vote 65 (17.9) 52 (22.6) 1.16 (0.74–1.80) 125 (30.2) 2.25 (1.53–3.30)
Optimism
 Low/low-intermed 154 (42.4) 110 (47.8) 1 207 (50.0) 1
 Intermed-high/high 209 (57.6) 120 (52.2) 0.98 (0.67–1.43) 207 (50.0) 0.71 (0.51–0.99)
Resilience
 Low/low-intermed 179 (49.3) 131 (57.0) 1 193 (46.6) 1
 Intermed-high/high 184 (50.7) 99 (43.0) 0.91 (0.63–1.33) 221 (53.4) 1.37 (0.98–1.92)
Need for cognitive closure
 Low/low-intermed 176 (48.5) 130 (56.5) 1 194 (46.9) 1
 Intermed-high/high 187 (51.5) 100 (43.5) 0.71 (0.50–0.99) 220 (53.1) 1.01 (0.74–1.36)
Main source to inform oneself about measures/recommendations
 TV 216 (59.5) 100 (43.5) 1.03 (0.72–1.48) 226 (54.6) 0.88 (0.64–1.20)
Subjective health status
 Very good 97 (26.7) 55 (23.9) 1 128 (30.9) 1
 Good 185 (51.0) 116 (50.4) 1.05 (0.69–1.60) 175 (42.3) 0.70 (0.49–1.01)
 Fair, bad or very bad 81 (22.3) 59 (25.7) 1.23 (0.73–2.05) 111 (26.8) 0.98 (0.63–1.53)

*Risk estimates are ORs with 95% CIs adjusted for all variables presented in the table.

Table 3.

Correlates of vaccine hesitancy among participants (N = 654) who indicated overall adherence to COVID-19 measures and reported an ‘altruistic’ reason# for their adherence

Vaccine hesitance
No or little hesitancy (N = 286) Undecided (N = 156) Intermediate or high hesitancy (N = 212)
N (%) N (%) OR (95% CI)* N (%) OR (95% CI)*
Gender
 Men 154 (53.9) 71 (45.5) 0.74 (0.49–1.11) 71 (33.5) 0.42 (0.28–0.63)
Age
 <35 years 82 (28.6) 61 (39.1) 1 66 (31.1) 1
 35–54 years 120 (42.0) 72 (46.1) 0.68 (0.42–1.10) 113 (53.3) 1.01 (0.64–1.61)
 55–59 years 40 (14.0) 16 (10.3) 0.39 (0.19–0.82) 23 (10.9) 0.56 (0.28–1.10)
 ≥60 years 44 (15.4) 7 (4.5) 0.17 (0.07–0.42) 10 (4.7) 0.21 (0.09–0.50)
Area of residenc
 Urban 168 (58.7) 67 (43.0) 1 82 (38.7) 1
 Rural ≥ 50.000 inhabitants 11 (3.9) 9 (5.7) 2.09 (0.80–5.46) 9 (4.2) 1.50 (0.56–4.01)
 Rural < 50.000 inhabitants 107 (37.4) 80 (51.3) 1.93 (1.27–2.95) 121 (57.1) 2.27 (1.52–3.38)
Education
 High school or less 93 (32.5) 58 (37.2) 1 98 (46.2) 1
 Matura (university entry exam) 114 (39.9) 61 (39.1) 0.77 (0.47–1.25) 72 (34.0) 0.65 (0.41–1.03)
 University degree 79 (27.6) 37 (23.7) 0.66 (0.38–1.15) 42 (19.8) 0.49 (0.29–0.82)
Political party preference
 Governing 157 (54.9) 87 (55.8) 1 88 (41.5) 1
 Opposition 80 (28.0) 34 (21.8) 0.88 (0.53–1.77) 56 (26.4) 1.53 (0.96–2.46)
 Did not vote (last elections) 49 (17.1) 35 (22.4) 1.13 (0.67–1.92) 68 (32.1) 2.16 (1.33–3.51)
Optimism
 Low or low-intermediate 114 (39.9) 63 (40.4) 1 100 (47.2) 1
 Intermediate-high or high 172 (60.1) 93 (59.6) 1.13 (0.72–1.77) 112 (52.8) 0.77 (0.50–1.19)
Resilience
 Low or low-intermediate 137 (47.9) 74 (47.4) 1 94 (44.3) 1
 Intermediate-high or high 149 (52.1) 82 (52.6) 1.24 (0.80–1.93) 118 (55.7) 1.49 (0.97–2.28)
Need for cognitive closure
 Low or low-intermediate 144 (50.4) 82 (52.6) 1 100 (47.2) 1
 Intermediate-high or high 142 (49.6) 74 (47.4) 0.86 (0.57–1.30) 112 (52.8) 0.95 (0.64–1.40)
Main source to inform oneself about measures/recommendations
 TV 114 (39.9) 62 (39.7) 1.20 (0.79–1.83) 88 (41.5) 1.11 (0.75–1.66)
Subjective health status
 Very good 76 (26.6) 39 (25.0) 1 63 (29.7) 1
 Good 148 (51.7) 83 (53.2) 1.08 (0.66–1.78) 90 (42.5) 0.70 (0.44–1.11)
 Fair, bad or very bad 62 (21.7) 34 (21.8) 1.15 (0.61–2.15) 59 (27.8) 1.02 (0.58–1.79)

#Protection of family’s health, protection of the population’s health, or not wanting to cause the death of another person.

*Risk estimates are ORs with 95% confidence intervals adjusted for all variables presented in the table.

In secondary analyses, we stratified our sample by grouping participants’ answers into altruistic reasons (Table 3) versus non-altruistic reasons (Table 4) for behaviour towards Corona measures, as described in the Methods section. Among the 654 participants who were categorized as reporting ‘altruistic reasons’ as primary drivers for their behaviour during the pandemic [358 women (54.7%) and 296 men (45.2%)], correlations between covariables and vaccine hesitancy remained similar to overall though they were slightly more pronounced for men, higher age (60+), and small rural areas (Table 3), suggesting that these groups were least hesitant towards a COVID-19 vaccine. For the group who did not report any of the three selected altruistic reasons (n = 271, 119 women (43.9%) and 152 men (56.1%), Table 4), the most striking differences among those with hesitancy towards a COVID-19 vaccine were that the odds of having higher education appeared less pronounced (OR = 0.81; 95%CI, 0.33–1.99), compared to the total sample; and that the odds of having voted for opposition parties was 3.5-times that of those who voted for the governing parties. Overall, trust in the Austrian government to provide a safe vaccine was low (53.8% indicated rather or definitely not trust), whereas the desire for independent scientific evaluations regarding vaccine safety to increase willingness to vaccine was high (80.7%).

Table 4.

Correlates of vaccine hesitancy among participants (N = 271) who indicated overall adherence to COVID-19 measures and did not report an ‘altruistic’ reason# for their adherence

Vaccine hesitancy
No or little hesitancy (N = 65) Undecided (N = 57) Intermediate or high hesitancy (N = 149)
N (%) N (%) OR (95% CI)* N (%) OR (95% CI)*
Gender
 Men 42 (64.6) 34 (59.7) 0.66 (0.29–1.48) 75 (50.3) 0.50 (0.24–0.92)
Age
 <35 years 17 (26.1) 23 (40.3) 1 38 (25.5) 1
 35–54 years 23 (35.4) 24 (42.1) 0.89 (0.34–2.32) 81 (54.4) 1.48 (0.64–3.42)
 55–59 years 12 (18.5) 3 (5.3) 0.21 (0.05–0.99) 10 (6.7) 0.31 (0.10–1.01)
 ≥60 years 13 (20.0) 7 (12.3) 0.46 (0.13–1.62) 20 (13.4) 0.46 (0.16–1.29)
Area of residence
 Urban 23 (35.4) 27 (47.4) 1 70 (46.9) 1
 Rural ≥ 50.000 inhabitants 8 (12.3) 5 (8.7) 0.53 (0.13–2.10) 5 (3.4) 0.16 (0.04–0.61)
 Rural < 50.000 inhabitants 34 (52.3) 25 (43.9) 0.59 (0.26–1.35) 74 (49.7) 0.77 (0.39–1.50)
Education
 High school or less 25 (38.5) 21 (36.8) 1 71 (47.7) 1
 Matura (university entry exam) 27 (41.5) 27 (47.4) 0.97 (0.40–2.38) 47 (31.5) 0.57 (0.27–1.20)
 University degree 13 (20.0) 9 (15.8) 0.74 (0.24–2.29) 31 (20.8) 0.81 (0.33–1.99)
Political party preference
 Governing 37 (57.0) 29 (50.9) 1 52 (34.9) 1
 Opposition 14 (21.5) 16 (28.1) 1.65 (0.64–4.22) 56 (37.6) 3.58 (1.61–7.94)
 Did not vote (last elections) 14 (21.5) 12 (21.0) 0.79 (0.28–2.17) 41 (27.5) 1.82 (0.81–4.12)
Optimism
 Low or low-intermediate 31 (47.7) 35 (61.4) 1 79 (53.0) 1
 Intermediate-high or high 34 (52.3) 22 (38.6) 0.82 (0.34–1.99) 70 (47.0) 0.65 (0.31–1.38)
Resilience
 Low or low-intermediate 32 (49.2) 43 (75.4) 1 71 (47.7) 1
 Intermediate-high or high 33 (50.8) 14 (24.6) 0.36 (0.14–0.90) 78 (52.3) 1.19 (0.58–2.45)
Need for cognitive closure
 Low or low-intermediate 23 (35.4) 34 (59.7) 1 63 (42.3) 1
 Intermediate-high or high 42 (64.6) 23 (40.4) 0.40 (0.18–0.89) 86 (57.7) 0.86 (0.44–1.68)
Main source to inform oneself about measures/recommendations
 TV 40 (61.5) 30 (52.6) 0.88 (0.39–1.99) 77 (51.9) 0.61 (0.31–1.21)
Subjective health status
 Very good 20 (30.8) 16 (28.1) 1 49 (32.9) 1
 Good 28 (43.1) 27 (47.4) 1.09 (0.42–2.81) 62 (41.6) 1.10 (0.50–2.42)
 Fair, bad or very bad 17 (26.1) 14 (24.5) 0.76 (0.25–2.33) 38 (25.5) 0.90 (0.36–2.23)

#Protection of family’s health, protection of the population’s health, or not wanting to cause the death of another person.

*Risk estimates are ORs with 95% CI adjusted for all variables presented in the table.

Because voting behavior was the strongest correlate of vaccine hesitancy in our sample, we examined characteristics of the survey respondents stratified by voting behavior (voted for parties in power; voted for opposing parties; did not vote). We observed that the characteristics of those who did not vote during the last national election resembled those of persons with intermediate to high vaccine hesitancy: non-voters tended to be female, younger (<35 years), were more likely from the Austrian federal states Styria or Tyrol, more likely to be less educated (high school or less), they were substantially more likely to have vaccine hesitancy, less optimistic and to use as main source of information about the Corona pandemic their friends or social media, and to do so less frequently, compared to those who voted (regardless whether they voted for the parties in power or the opposition parties). In addition, they were more likely to perceive the risk of infecting themselves with COVID-19 as negligible or low, their subjective health status tended to be worse, and their life quality more likely to have changed for the worse during the pandemic, compared to Austrians who had voted during the last national election (Supplementary eTable 1).

Discussion

Main findings of this study

In our study, which reflects the main demographics of the Austrian population, 53.8% declared that they did not trust the Austrian government with respect to a safe vaccine, and merely 36.1% indicated that they would be likely to get vaccinated once a COVID-19 vaccine is available in Austria (with 22.8% undecided). In line with previous reports, the unwillingness to vaccinate was higher among women and younger Austrians9,10; but also among those in favor of political opposition parties (47.2%) or who did not vote in the last national election (51.6%) whereas it was lowest among survey respondents who indicated that they had voted for the parties in power (32.2%). By contrast, psychosocial concepts, with the exception of optimism, were not strongly correlated with willingness to vaccinate.

What is already known on this topic

A survey from 2015, conducted among 350 patients visiting an emergency department in Austria has previously demonstrated high hesitancy towards vaccines with 50.3% having some reservations or no trust at all in vaccines, citing distrust in pharmaceutical industry, doubts regarding vaccines’ effectiveness, and fear of side effects.11 Physicians were the most trusted source of information regarding vaccines in that, as well as another small survey conducted in 2016 among a rural population (n = 306) in Austria.12 Clearly, against the backdrop of this general phenomenon of vaccine refusal in Austria, attitudes towards the COVID-19 vaccine warrant particular attention.

In our sample, vaccine hesitancy and voting behavior seem to converge. Reasons for rejecting Corona measures and protests against government interventions can have a wide variety of causes.13 The last Austrian national election, to which our question about voting behavior referred was held on 29 September 2019, i.e. long enough before the pandemic began. Of note, voter turnout had dropped to 75.6%,—the second-lowest turnout ever.14 In this context, our findings may be indicative of more profound societal changes and increasing distrust in the political system that can currently be observed not only in Austria but to some extent in all Western democracies,15 considering conspicuous phenomena such as democracy or state deniers (similar to the German ‘Querdenker’ or US ‘QAnon’ movements that deny the existence of the Coronavirus pandemic, among other conspiracy theories). In fact, vaccine hesitancy could be seen as a symptom of a much deeper problem, namely rejection of government or state action. These sentiments may be driven by an underlying sense of mistrust and fear, which has been proven to be an important factor, particularly in the context of the severe acute respiratory syndrome (SARS-CoV-2) pandemic.16

What this study adds

Fear and uncertainty can be countered by improving the understanding of system complexity and the associated risks. In this context, the role and responsibilities of scientists must also be rethought. A current problem is the divergence of disciplinary perspectives even among scientists in the same discipline, which is proving counterproductive to building trust in proposed interventions or vaccines. These tendencies are exacerbated by scientists who become activists rather than following a rigorous scientific approach. Given the generally high level of distrust of government and the unfortunate politicization of much of the COVID-19 response, it is a call for scientists to become more assertive and communicate facts, gaps in current knowledge, and consequences for action independent of the political process. Because, among other things, the COVID-19 pandemic has shown that science can no longer be separated from society.

Mistrust and misinformation17 regarding a COVID-19 vaccine are widespread among the population worldwide, including in Austria. This could hinder pandemic response efforts and calls for a better understanding of those who exhibit particular vaccine hesitancy. Our findings of a strong correlation between vaccine hesitancy, unwillingness to follow Corona measures and political apathy or opposition are therefore relevant and troubling. They point to larger trends towards weakening societal cohesion and increasing distrust in institutions. Consistent with this, the Austrian Corona Panel Project18 found that satisfaction with government performance and the degree of solidarity in Austrian society had already declined from April to June 2020.

Limitations of this study

Our study has several limitations of note, which include its cross-sectional nature and reliance on self-report for many covariables. Because the survey was conducted online, our reach of age groups beyond age 70 was limited due to their restricted use of digital media.

In conclusion, our results reflect a lack of trust in the political system,15,19 but indicate that there is possibility for improvement. In our survey, more than 80% wanted to see the results of an independent scientific evaluation of the vaccine before getting vaccinated. This supports—as previously suggested by Bauchner et al.20 and Cordero21—that an independent and de-politicized, rigorous, science-based evaluation of COVID-19 vaccines and transparent communication strategies22,23 can increase the willingness to be vaccinated. As part of the vaccine rollout, it will thus be essential to invest in transparent and effective ways to communicate results and achievements to the broader public. Our findings further imply that a diversified communication strategy is needed to address all citizens. Future studies should examine the extent of the relationship between trust in government and interventions, such as vaccination, in an international comparison to form the basis for meta-national communication and intervention strategies in dealing with pandemic threats.

Methods

Study population

Data collection was performed implementing a non-probability online survey between 26 November and 3 December 2020 among 1007 Austrian adults, quota sampled to match the population for age, gender and region. The survey was designed by members of the research team and implemented by the market research institute INTERROGARE, Bielefeld, Germany, using online panels to select participants who were representative of the Austrian population in terms of their residence, gender, and age. Because the survey was implemented online, only age groups up to around age 70 were reached (due to the still low digital literacy rate among higher age groups in Austria).

The survey was answered by 1007 adult participants aged 18 to 70 (498 male and 509 female), and comprised 60 questions on lifestyle, health and COVID-19 related measures and behaviour as well as attitudes toward a COVID-19 vaccine once available. It took on average 15 minutes to complete. Participants’ consent was implied by filling in the online survey. The study was exempt from Institutional Review Board approval according to Federal Regulations 45 CFR 46.10(b).

Covariables

In addition to age, gender, lifestyle (smoking behaviour, body mass index, alcohol, caffeine consumption, diet, physical activity), health (previous SARS-CoV-2 infection; general health status, chronic disease history, use of supplements or medication, mental/emotional health) and sociodemographic variables (employment status, occupation, education, marital status, voting behaviour during last national elections, which took place in September 2019), several psychosocial attributes were also assessed, including optimism (using the validated Life Orientation Test LOT-revised24), resilience (using a German version25 of the resilience scale by Wagnild and Young,26 and need for cognitive closure (using the German short scale ‘need for cognitive closure’,27 validated according to the personality construct ‘need for cognitive closure’ (NCC) by Webster and Kruglanski28).

Regarding the pandemic and COVID-19, the survey elicited information on whether or not participants worked from home during the pandemic, use of media (and which type) to receive information about COVID, change in life quality since the beginning of the pandemic, what helped most to cope with COVID measures (predefined categories), and knowledge regarding, agreement with and acceptance of COVID measures that remained implemented by the Austrian government after the first wave/lockdown (June–September 2020), which included hand hygiene, reduction of social contacts and travel restrictions. Further, specific reasons (in predefined categories, with an open category for additional answers) for adherence (or not adhering) to Corona measures were elicited, and grouped to reflect more likely altruistic reasons, versus non-altruistic (i.e. self-centered) ones. The survey also elicited information regarding vaccine attitudes. Participants were asked how likely they would be to get vaccinated once a COVID-19 vaccine was available, need to independent scientific evaluation before vaccination; trust in Austrian government with regard to the safety of a COVID-19 vaccine, and dependence of vaccine acceptance on subsequent loosening of travel or other COVID restrictions.

Statistical methods

Descriptive statistics were used to summarize the frequency and distribution of study population characteristics among Austrians, in the full sample and stratified by vaccine hesitancy. Summary statistics [mean, standard deviation (SD), or medians and interquartile ranges, and frequency (N and %)] were used to describe the characteristics or predictors of vaccine hesitancy in three groups (not hesitant, undecided and hesitant).

All analyses were conducted in the total population and stratified by gender. We present characteristics additionally stratified by voting behaviour during the last national election in Austria, which took place on 29 September 2019: voted for parties in power; opposition parties; or did not vote. In our primary analyses, we used age- and gender-adjusted (gender only in models using the total population), as well as multivariable adjusted multinomial logistic regression models to examine the association between various variables and vaccine hesitancy, and report OR and 95% CIs. In addition to age and gender, the multivariable models adjusted for the following covariables: area of residence (urban; rural ≥50.000 inhabitants; rural < 50.000 inhabitants); education (high school or less; Matura i.e. University entry exam, University degree); which party voted for during most recent national election (governing; opposition; did not vote); optimism scale, resilience scale and need for cognitive closure (each grouped into low or low-intermediate versus intermediate-high or high); main source to inform oneself about Corona (TV versus not using TV to inform oneself); subjective health status (very good; good; fair, bad or very bad).

Secondarily, we stratified by two groups of reasons for adherence (or non-adherence) to Corona measures, which we derived from a separate question that elicited reasons for adherence (or not adhering) to Corona measures. From all possible answers, we grouped as ‘altruistic reasons’ those participants who stated that either ‘protection of family’s health’ or ‘protection of the population’s health’ or ‘because they did not want to cause deaths’ were their primary reasons for adhering to COVID measures (n = 654) whereas those who listed none of these three reasons were grouped as ‘non-altruistic reasons’ (n = 271). A two-sided p-value of 0.05 or lower was considered statistically significant. All data analyses were performed using STATA (version 14.1, 2015, StataCorp LP).

Acknowledgements

We thank the respondents to this survey for their participation.

The authors declare no competing interests.

Eva Schernhammer, Professor

Jakob Weitzer, Research Assistant

Manfred D. Laubichler, Professor

Brenda M. Birmann, Assistant Professor

Martin Bertau, Professor

Lukas Zenk, Assistant Professor

Guido Caniglia, Professor

Carlo C. Jäger, Professor

Gerald Steiner, Professor

Contributor Information

Eva Schernhammer, Department of Epidemiology, Center for Public Health, Medical University of Vienna, 1090 Vienna, Austria; Complexity Science Hub, 1080 Vienna, Austria; Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA.

Jakob Weitzer, Department of Epidemiology, Center for Public Health, Medical University of Vienna, 1090 Vienna, Austria.

Manfred D Laubichler, Complexity Science Hub, 1080 Vienna, Austria; School of Complex Adaptive Systems, Arizona State University, Tempe, AZ 85287, USA; Santa Fe Institute, Santa Fe, NM 87501, USA.

Brenda M Birmann, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA.

Martin Bertau, Institute for Technical Chemistry, TU Bergakademie Freiberg, 09599 Freiberg, Germany.

Lukas Zenk, Department for Knowledge and Communication Management, Danube University Krems, 3500 Krems and der Donau, Austria.

Guido Caniglia, Konrado Lorenz Institute for Evolution and Cognition Research, 3400 Klosterneuburg, Austria.

Carlo C Jäger, Global Climate Forum, 10178 Berlin, Germany.

Gerald Steiner, Complexity Science Hub, 1080 Vienna, Austria; Institute for Technical Chemistry, TU Bergakademie Freiberg, 09599 Freiberg, Germany.

References

  • 1. Kreidl  P, Schmid  D, Maritschnik  S  et al.  Emergence of coronavirus disease 2019 (COVID-19) in Austria. Wien Klin Wochenschr  2020;132:645–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Moshammer  H, Poteser  M, Lemmerer  K  et al.  Time course of COVID-19 cases in Austria. Int J Environ Res Public Health  2020;17. doi: 10.3390/ijerph17093270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Lazarus  JV, Ratzan  SC, Palayew  A  et al.  A global survey of potential acceptance of a COVID-19 vaccine. Nat Med  2020. doi: 10.1038/s41591-020-1124-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Caserotti  M, Girardi  P, Rubaltelli  E  et al.  Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc Sci Med  2021;272:113688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Wang  K, Wong  ELY, Ho  KF  et al.  Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines (Basel)  2021;9. doi: 10.3390/vaccines9010062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Murphy  J, Vallières  F, Bentall  RP  et al.  Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun  2021;12:29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Kreps  S, Prasad  S, Brownstein  JS  et al.  Factors associated with US Adults' likelihood of accepting COVID-19 vaccination. JAMA Netw Open  2020;3:e2025594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Volpp  KG, Loewenstein  G, Buttenheim  AM. Behaviorally informed strategies for a national COVID-19 vaccine promotion program. JAMA  2020. doi: 10.1001/jama.2020.24036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Sallam  M, Dababseh  D, Eid  H  et al.  High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines (Basel)  2021;9. doi: 10.3390/vaccines9010042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Freeman  D, Loe  BS, Chadwick  A  et al.  COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med  2020;1–15. doi: 10.1017/S0033291720005188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Sandhofer  MJ, Robak  O, Frank  H  et al.  Vaccine hesitancy in Austria: a cross-sectional survey. Wien Klin Wochenschr  2017;129:59–64. [DOI] [PubMed] [Google Scholar]
  • 12. Bauer  A, Tiefengraber  D, Wiedermann  U. Towards understanding vaccine hesitancy and vaccination refusal in Austria. Wien Klin Wochenschr  2020. doi: 10.1007/s00508-020-01777-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Dror  AA, Eisenbach  N, Taiber  S  et al.  Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol  2020;35:775–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Republik Österreich  Parlament. Wie viele gehen zur Wahl? Die Entwicklung der Wahlbeteiligung, Vienna, Austria: Parliament of the Republic of Austria. https://www.parlament.gv.at/PERK/HIS/WAHL/BETEIL/index.shtml (7 April 2021, date last accessed).
  • 15. Burgess  AR, Osborne  RH, Yongabi  KA  et al.  The COVID-19 vaccines rush: participatory community engagement matters more than ever. Lancet online first  2020. doi: 10.1016/S0140-6736(20)32642-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Brentler, A. Interview mit Nadine Frei und Robert Schäfer, Jacobin Magazine, Berlin, Germany: Brumaire. https://jacobin.de/artikel/corona-proteste-querdenker-verschwoerungstheorien-studie-uni-basel/?fbclid=IwAR0-YU7Fq3wBd6nCyjDZjIPLuZ62eAnlHM4KFS_isq54klBvKE2vktkC9-Y (7 April 2021, date last accessed).
  • 17. Puri  N, Coomes  EA, Haghbayan  H  et al.  Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother  2020;16:2586–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Vienna, U. O. Austrian Corona Panel Project, Vienna, Austria: University of Vienna, Faculty of Social Sciences. https://viecer.univie.ac.at/en/projects-and-cooperations/austrian-corona-panel-project/ (7 April 2021, date last accessed).
  • 19. Palamenghi  L, Barello  S, Boccia  S  et al.  Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol  2020;35:785–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Bauchner  H, Malani  PN, Sharfstein  J. Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine. JAMA  2020;324:1296–7. [DOI] [PubMed] [Google Scholar]
  • 21. Cordero  DA. Rebuilding public trust: a clarified response to COVID-19 vaccine hesitancy predicament. J Public Health (Oxf)  2021. doi: 10.1093/pubmed/fdab020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Chou  WS, Budenz  A. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun  2020;35:1718–22. [DOI] [PubMed] [Google Scholar]
  • 23. Vergara  RJD, Sarmiento  PJD, Lagman  JDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health (Oxf)  2021. doi: 10.1093/pubmed/fdaa282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hinz  A, Sander  C, Glaesmer  H  et al.  Optimism and pessimism in the general population: psychometric properties of the life orientation test (LOT-R). Int J Clin Health Psychol  2017;17:161–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Schumacher  J, Leppert  K, Gunzelrnann  T  et al.  Die Resilienzskala-Ein Fragebogen zur Erfassung der psychischen Widerstandsfähigkeit als Personmerkmal. Z Klin Psychol Psychiatr Psychother  2005;53:16–39. [Google Scholar]
  • 26. Wagnild  GM, Young  HM. Development and psychometric evaluation of the resilience scale. J Nurs Meas  1993;1:165–78. [PubMed] [Google Scholar]
  • 27. Schlink  S, Walther  E. Kurzundgut: Eine deutsche Kurzskala zur Erfassung des Bedürfnisses nach kognitiver Geschlossenheit. Zeitschrift Sozialpsychologie  2007;38:153–61. [Google Scholar]
  • 28. Webster  DM, Kruglanski  AW. Individual differences in need for cognitive closure. J Pers Soc Psychol  1994;67:1049–62. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Public Health (Oxford, England) are provided here courtesy of Oxford University Press

RESOURCES